Telix Pharmaceuticals | TLX - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Cochlear AUD 6.3M 3.65M 2025-12
CSL USD 215M 111M 2025-12
Integral Diagnostics AUD 5.34M 6.08M 2024-06
Mayne Pharma AUD 1.2M 50K 2024-06
Medical Developments International AUD 18K 3K 2025-06
Mesoblast USD 11.29M 461K 2025-12
Neuren Pharmaceuticals AUD 0 0 2024-06
Paradigm Biopharmaceuticals AUD 1000 3K 2025-06
Polynovo AUD 506K 130K 2025-06
PYC Therapeutics AUD 17K 11K 2025-06
Ramsay Health Care AUD 300.6M 15.5M 2025-12
ResMed USD 775K 886K 2024-12
Sonic Healthcare AUD 86.91M 43.94M 2024-12